Here, we substantiated those findings and extended them to breast cancer, where we implicate FasL-expressing MDSCs as part of a broader pathway that links host obesity to heightened CD8 TIL apoptosis and immunotherapy resistance. The gene discussed is FASLG; the disease is obesity due to melanocortin 4 receptor deficiency.